 Benedetto Mungo
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophagectomy | 13 | 2023 | 111 | 1.970 |
Why?
| | Esophageal Neoplasms | 11 | 2023 | 273 | 1.780 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 85 | 1.210 |
Why?
| | Thoracic Surgery, Video-Assisted | 3 | 2016 | 40 | 1.120 |
Why?
| | Pancreatic Neoplasms | 3 | 2022 | 731 | 1.060 |
Why?
| | Laparoscopy | 5 | 2017 | 398 | 0.930 |
Why?
| | Postoperative Complications | 13 | 2023 | 2128 | 0.870 |
Why?
| | Hernia, Hiatal | 4 | 2017 | 31 | 0.630 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 211 | 0.630 |
Why?
| | Herniorrhaphy | 3 | 2014 | 48 | 0.590 |
Why?
| | Pneumonectomy | 2 | 2016 | 125 | 0.560 |
Why?
| | Colectomy | 1 | 2017 | 86 | 0.550 |
Why?
| | Anastomosis, Surgical | 3 | 2015 | 136 | 0.530 |
Why?
| | Neoadjuvant Therapy | 3 | 2015 | 304 | 0.530 |
Why?
| | Lymph Node Excision | 2 | 2016 | 139 | 0.520 |
Why?
| | Adenocarcinoma | 3 | 2016 | 795 | 0.510 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2023 | 154 | 0.510 |
Why?
| | Retrospective Studies | 23 | 2023 | 12542 | 0.500 |
Why?
| | Colonic Neoplasms | 1 | 2017 | 215 | 0.500 |
Why?
| | Length of Stay | 10 | 2017 | 962 | 0.490 |
Why?
| | Lung Neoplasms | 2 | 2016 | 2177 | 0.420 |
Why?
| | Databases, Factual | 7 | 2017 | 1124 | 0.360 |
Why?
| | Treatment Outcome | 16 | 2023 | 9084 | 0.360 |
Why?
| | Aged | 21 | 2017 | 19061 | 0.350 |
Why?
| | Operative Time | 4 | 2015 | 106 | 0.290 |
Why?
| | Middle Aged | 18 | 2017 | 26719 | 0.280 |
Why?
| | Patient Readmission | 3 | 2017 | 609 | 0.270 |
Why?
| | Esophageal Diseases | 2 | 2017 | 24 | 0.270 |
Why?
| | Obesity | 2 | 2015 | 2507 | 0.260 |
Why?
| | Thoracic Surgery | 2 | 2017 | 106 | 0.250 |
Why?
| | General Surgery | 2 | 2017 | 127 | 0.250 |
Why?
| | Quality Improvement | 4 | 2017 | 950 | 0.250 |
Why?
| | Aged, 80 and over | 10 | 2017 | 6344 | 0.240 |
Why?
| | Stomach | 2 | 2015 | 102 | 0.220 |
Why?
| | Risk Factors | 8 | 2017 | 8628 | 0.210 |
Why?
| | Humans | 30 | 2023 | 114624 | 0.210 |
Why?
| | Specialties, Surgical | 1 | 2023 | 70 | 0.210 |
Why?
| | Pancreatic Fistula | 1 | 2022 | 21 | 0.210 |
Why?
| | Anastomotic Leak | 2 | 2023 | 27 | 0.200 |
Why?
| | Female | 25 | 2017 | 59466 | 0.200 |
Why?
| | Logistic Models | 6 | 2017 | 1840 | 0.190 |
Why?
| | Natural Orifice Endoscopic Surgery | 2 | 2012 | 26 | 0.190 |
Why?
| | Male | 21 | 2017 | 55555 | 0.190 |
Why?
| | Pancreaticoduodenectomy | 1 | 2022 | 133 | 0.190 |
Why?
| | United States | 11 | 2023 | 12176 | 0.190 |
Why?
| | Pancreatectomy | 1 | 2022 | 171 | 0.180 |
Why?
| | Hospital Mortality | 5 | 2017 | 776 | 0.180 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2016 | 577 | 0.170 |
Why?
| | Surgeons | 1 | 2023 | 239 | 0.170 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2020 | 60 | 0.170 |
Why?
| | Reoperation | 3 | 2016 | 514 | 0.170 |
Why?
| | Adult | 11 | 2017 | 30528 | 0.160 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 442 | 0.160 |
Why?
| | Thoracotomy | 2 | 2016 | 75 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1430 | 0.160 |
Why?
| | Body Mass Index | 2 | 2015 | 1956 | 0.150 |
Why?
| | Lymph Nodes | 2 | 2016 | 419 | 0.140 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 47 | 0.140 |
Why?
| | Esophageal Mucosa | 1 | 2016 | 17 | 0.140 |
Why?
| | Esophagoplasty | 1 | 2016 | 1 | 0.140 |
Why?
| | Optical Imaging | 1 | 2016 | 54 | 0.130 |
Why?
| | Specialization | 1 | 2017 | 115 | 0.130 |
Why?
| | Lymphatic Vessels | 1 | 2016 | 54 | 0.130 |
Why?
| | Conversion to Open Surgery | 1 | 2016 | 14 | 0.130 |
Why?
| | Age Factors | 4 | 2014 | 2894 | 0.120 |
Why?
| | Talc | 1 | 2014 | 5 | 0.120 |
Why?
| | Pleurodesis | 1 | 2014 | 7 | 0.120 |
Why?
| | Hepatic Artery | 1 | 2014 | 49 | 0.120 |
Why?
| | Thoracic Diseases | 1 | 2014 | 13 | 0.120 |
Why?
| | Thinness | 1 | 2015 | 87 | 0.120 |
Why?
| | Tissue Adhesions | 1 | 2014 | 26 | 0.120 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2014 | 45 | 0.120 |
Why?
| | Matched-Pair Analysis | 1 | 2014 | 33 | 0.120 |
Why?
| | Endometriosis | 1 | 2014 | 40 | 0.110 |
Why?
| | Respiration Disorders | 1 | 2014 | 69 | 0.110 |
Why?
| | Thoracic Surgical Procedures | 1 | 2014 | 57 | 0.110 |
Why?
| | Leukocyte Count | 1 | 2014 | 293 | 0.110 |
Why?
| | Standard of Care | 1 | 2014 | 62 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 91 | 0.110 |
Why?
| | Postoperative Period | 1 | 2014 | 289 | 0.110 |
Why?
| | Esophageal Achalasia | 1 | 2013 | 25 | 0.110 |
Why?
| | Sarcoma | 1 | 2014 | 137 | 0.110 |
Why?
| | Urinary Tract Infections | 1 | 2014 | 134 | 0.110 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 243 | 0.100 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 287 | 0.100 |
Why?
| | Gastroscopes | 1 | 2012 | 3 | 0.100 |
Why?
| | Surgical Stapling | 1 | 2012 | 9 | 0.100 |
Why?
| | Jejunum | 1 | 2012 | 24 | 0.100 |
Why?
| | Chemoradiotherapy | 1 | 2013 | 188 | 0.100 |
Why?
| | Rothmund-Thomson Syndrome | 1 | 2011 | 1 | 0.100 |
Why?
| | Surgical Wound Infection | 1 | 2014 | 248 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2015 | 490 | 0.090 |
Why?
| | Neoplasms | 2 | 2015 | 2097 | 0.090 |
Why?
| | Esophageal Stenosis | 1 | 2011 | 45 | 0.090 |
Why?
| | Venous Thromboembolism | 1 | 2014 | 231 | 0.090 |
Why?
| | Fundoplication | 3 | 2017 | 53 | 0.090 |
Why?
| | Liver Neoplasms | 1 | 2014 | 506 | 0.090 |
Why?
| | Catheterization | 1 | 2011 | 159 | 0.090 |
Why?
| | Ileum | 1 | 2011 | 90 | 0.090 |
Why?
| | Rectum | 1 | 2011 | 153 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2013 | 355 | 0.080 |
Why?
| | Weight Loss | 1 | 2014 | 641 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1394 | 0.070 |
Why?
| | Biomarkers | 2 | 2014 | 3408 | 0.070 |
Why?
| | Feasibility Studies | 3 | 2016 | 739 | 0.070 |
Why?
| | Lymphatic Metastasis | 2 | 2016 | 275 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1355 | 0.060 |
Why?
| | Young Adult | 3 | 2015 | 10455 | 0.060 |
Why?
| | Chi-Square Distribution | 2 | 2016 | 493 | 0.060 |
Why?
| | Odds Ratio | 2 | 2016 | 953 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2016 | 4411 | 0.050 |
Why?
| | Lung | 1 | 2014 | 3558 | 0.050 |
Why?
| | Adolescent | 3 | 2015 | 17831 | 0.050 |
Why?
| | Survival Rate | 2 | 2016 | 1644 | 0.050 |
Why?
| | Time Factors | 3 | 2016 | 6112 | 0.050 |
Why?
| | Models, Animal | 2 | 2012 | 344 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 508 | 0.040 |
Why?
| | Comorbidity | 2 | 2014 | 1448 | 0.040 |
Why?
| | Incidence | 2 | 2016 | 2311 | 0.040 |
Why?
| | Swine | 2 | 2012 | 700 | 0.040 |
Why?
| | Gastric Fundus | 1 | 2017 | 3 | 0.040 |
Why?
| | Indocyanine Green | 1 | 2016 | 12 | 0.030 |
Why?
| | Maryland | 1 | 2016 | 37 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1317 | 0.030 |
Why?
| | Baltimore | 1 | 2015 | 43 | 0.030 |
Why?
| | Sierra Leone | 1 | 2014 | 2 | 0.030 |
Why?
| | Esophagoscopy | 1 | 2016 | 184 | 0.030 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2015 | 40 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 2016 | 301 | 0.030 |
Why?
| | Breast Diseases | 1 | 2014 | 20 | 0.030 |
Why?
| | Uterine Diseases | 1 | 2014 | 14 | 0.030 |
Why?
| | Gastroplasty | 1 | 2014 | 26 | 0.030 |
Why?
| | Hospital Charges | 1 | 2013 | 39 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1211 | 0.030 |
Why?
| | Developing Countries | 1 | 2014 | 235 | 0.030 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2014 | 188 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1075 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2014 | 620 | 0.030 |
Why?
| | Remission Induction | 1 | 2013 | 233 | 0.030 |
Why?
| | Neoplasm, Residual | 1 | 2013 | 104 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 2013 | 82 | 0.030 |
Why?
| | Malnutrition | 1 | 2013 | 62 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2014 | 539 | 0.030 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 216 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 275 | 0.030 |
Why?
| | Pilot Projects | 1 | 2016 | 1372 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2015 | 1167 | 0.020 |
Why?
| | Recurrence | 1 | 2014 | 935 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2014 | 234 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 560 | 0.020 |
Why?
| | Health Status | 1 | 2016 | 722 | 0.020 |
Why?
| | Hypothyroidism | 1 | 2011 | 64 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 471 | 0.020 |
Why?
| | Colonic Diseases | 1 | 2011 | 25 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2014 | 529 | 0.020 |
Why?
| | Anal Canal | 1 | 2011 | 84 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 208 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2013 | 350 | 0.020 |
Why?
| | Pneumonia | 1 | 2014 | 567 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 771 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 2249 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 913 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 2967 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2014 | 4405 | 0.010 |
Why?
| | Cohort Studies | 1 | 2013 | 4894 | 0.010 |
Why?
| | Heart Failure | 1 | 2013 | 1945 | 0.010 |
Why?
| | Animals | 2 | 2012 | 31695 | 0.010 |
Why?
| | Infant | 1 | 2011 | 7959 | 0.010 |
Why?
| | Child | 1 | 2014 | 18404 | 0.010 |
Why?
|
|
Mungo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|